Sonova, CH0012549785

Sonova stock holds steady on fiscal 2025 growth

Published on 07/23/2026 at 21:02 | Editorial responsibility: Rafael MĂĽller, Editor-in-Chief AD HOC NEWS

Sonova stock reflects fiscal 2025 revenue growth and stronger profit metrics as investors track the Swiss hearing-care group’s latest reported numbers.

A clean flatlay product photography arrangement on natural linen fabric showing a small generic unmarked hearing aid device, a soft cleaning brush, silver zinc-air button batteries, and a compact charging station dock with lid open, all neatly arranged wi
Sonova CH0012549785: Flatlay mit neutralem Hörgerät, Reinigungsbürste, Batterien und Ladestation auf Leinenstoff, Illustration mit AI erstellt.

Sonova Holding AG (CH0012549785) reported fiscal 2025 revenue of CHF 3.87 billion, up 7.6% at constant exchange rates, while EBIT before acquisition-related amortization rose to CHF 768.2 million and net profit reached CHF 547.3 million. The company’s latest reported year also included a free cash flow contribution of CHF 584.4 million, giving the Sonova stock story a clear earnings-and-cash focus.

Revenue up 7.6 percent

For fiscal 2025, Sonova posted CHF 3.87 billion in revenue, compared with CHF 3.59 billion in the prior year, according to the company’s investor reporting. The 7.6% constant-currency increase shows that growth remained in place even as the group faced a demanding comparison base.

EBIT before acquisition-related amortization advanced to CHF 768.2 million in fiscal 2025 from CHF 723.6 million a year earlier, while the operating margin improved to 19.9% from 20.2% in the prior year. The margin move is small, but the absolute profit line still added CHF 44.6 million year on year.

Profit and cash flow

Net profit for fiscal 2025 came in at CHF 547.3 million, up from CHF 533.0 million in fiscal 2024. Free cash flow reached CHF 584.4 million, compared with CHF 515.2 million a year earlier, showing that earnings translated into stronger cash generation as well.

That mix matters for Sonova stock because the company is not relying on one single line item. Revenue, profit, and cash all moved in the same direction in the latest reported year, which usually helps the market place a cleaner value on the business.

Read deeper

Sonova fiscal 2025 report details

The latest annual figures show how Sonova combined higher sales, firmer profit, and stronger cash flow in its reported year.

Hearing aids and implants

Sonova’s business remains anchored in hearing-care products, including hearing aids and related services, which are the main driver behind the group’s reported sales base. The company’s annual reporting also shows that the performance was not just a one-off accounting effect, because the revenue increase was paired with higher EBIT and free cash flow.

Stock level and market view

Sonova stock is quoted on SIX Swiss Exchange, and the company’s market capitalization and price data were not provided in the available search results for this call. The latest evidenced market story therefore rests on the fiscal 2025 numbers: CHF 3.87 billion revenue, CHF 768.2 million EBIT before acquisition-related amortization, and CHF 547.3 million net profit.

In that setting, the stock is being judged more on execution than on a single event headline. The comparison with fiscal 2024 remains the useful reference point: revenue rose from CHF 3.59 billion, EBIT before acquisition-related amortization increased from CHF 723.6 million, and free cash flow advanced from CHF 515.2 million.

Sonova company facts

Sonova Holding AG

  • Company: Sonova Holding AG
  • ISIN: CH0012549785
  • Ticker: SIX: SOON
  • Trading venue: SIX Swiss Exchange
  • Sector / Industry: Health Care / Health Care Equipment
  • Index membership: SMI
  • Price (as of 23 July 2026, 19:02 UTC): not provided in the available search results

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | CH0012549785 | SONOVA | boerse | 69855903 | bgmi